VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome
- 15 October 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (8) , 3003-3009
- https://doi.org/10.1182/blood-2003-05-1383
Abstract
Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29% of the MCLs displayed mutated VH using a 98% germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL. ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q– and 17p– showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.Keywords
This publication has 49 references indexed in Scilit:
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaCancer Cell, 2003
- Somatic hypermutation and VHgene usage in mantle cell lymphomaEuropean Journal of Haematology, 2002
- Properties of the mantle cell and mantle cell lymphomaCurrent Opinion in Hematology, 2002
- Mantle cell lymphoma is characterized by inactivation of the ATM geneProceedings of the National Academy of Sciences, 2000
- t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemiaGenes, Chromosomes and Cancer, 2000
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999
- Mantle cell lymphomaCancer, 1998
- Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(ll;14)(ql3;q32): a subtype of mantle cell lymphoma?British Journal of Haematology, 1995
- PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.Proceedings of the National Academy of Sciences, 1991
- Molecular Cloning of the Chromosomal Breakpoint of B-Cell Lymphomas and Leukemias with the t(11;14) Chromosome TranslocationScience, 1984